1. Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort.
- Author
-
Ueda-Hayakawa I, Fujimoto M, Sato S, Murakami A, Kawakami A, Mishima M, Seishima M, Suda T, Takehara K, Mimori T, and Kuwana M
- Subjects
- Adult, Aged, Antigens, Ly immunology, Autoantibodies immunology, Autoantibodies isolation & purification, Biomarkers blood, Dermatomyositis blood, Dermatomyositis immunology, Enzyme-Linked Immunosorbent Assay, Female, Humans, Interferon-Induced Helicase, IFIH1 immunology, Japan, Male, Mi-2 Nucleosome Remodeling and Deacetylase Complex immunology, Middle Aged, Retrospective Studies, Severity of Illness Index, Transcription Factors immunology, Urokinase-Type Plasminogen Activator immunology, Autoantibodies blood, Dermatomyositis diagnosis
- Abstract
Competing Interests: Declaration of Competing Interest Dr. Sato holds the patent for the anti-MDA5 antibody-measuring kit. Dr. Kuwana holds the patent for the anti-MDA5 antibody measuring kit, received consulting fees, speaking fees, and research grants from Abbie, Astellas, Asahi Kasei Parma, Boehringer-Ingelheim, Chugai, Corbus, Eisai, Janssen, MBL, Mochida, Nippon Shinyaku, Ono Pharmaceuticals, Pfizer, and Tanabe-Mitsubishi. A. Murakami is an employee of Medical and Biological Laboratories. This study was conducted as a collaboration between the authors’ institutes and Medical and Biological Laboratories. The remaining authors state that they have no other conflict of interest.
- Published
- 2021
- Full Text
- View/download PDF